Ferrrous Hemoglobin Scavenging of Endothelium Derived Nitric Oxide is a Principal Mechanism for Hemoglobin Mediated Vasoactivities in Isolated rat Thoracic Aorta

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 25, Issue 42006, 1997, Pages 121-133

  Kim, H W ^a   Greenburg, A G ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; ENZYME INHIBITION; ESTERS; HEMOGLOBIN; MUSCLE; NITROGEN OXIDES;

ENDOTHELIUM INDEPENDENT VASODILATORS; GLYCERYLTRINITRATE (GTN); ISOPROTERANOL (ISO); PAPAVERINE (PPV); STROMA FREE HEMOGLOBIN (SFH) SOLUTION; VASOCONSTRICTION;

BLOOD SUBSTITUTES;

ACETYLCHOLINE; ARGININE METHYL ESTER; CYCLIC GMP; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; ISOPRENALINE; METHEMOGLOBIN; NITRIC OXIDE; PAPAVERINE; ENZYME INHIBITOR; HEMOGLOBIN, STROMA FREE; LIGAND; N(G) NITROARGININE METHYL ESTER; NORADRENALIN; OXYHEMOGLOBIN; PLASMA SUBSTITUTE; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; MALE; NONHUMAN; RAT; SCAVENGING SYSTEM; SMOOTH MUSCLE RELAXATION; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HEMOGLOBINS; HUMANS; LIGANDS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; OXYHEMOGLOBINS; PLASMA SUBSTITUTES; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030610030     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199709118904     Document Type: Article

References (26)

1. Kim H. W., Rowley B. A., Feola M., Roberts L. A. The effect of stroma-free hemoglobin solution on the isolated perfused rabbit ventricular septum. Fed. Proc. 1983; 42 (4) 765
2. Kim H. W., Feola M., Rowley B. A., Roberts L. A. Effects of Hemoglobin Perfusion on Contractile Function of the Isolated Ventricular Septa. Biomat Art Cells Art Org 1988; 16: 331 – 345
3. Vogel M. W., Dennis R. C., Cassidy G., Apstein C. S., Valeri C. R. Coronary Constrictor Effect of Stroma-Free Hemoglobin Solutions. American Journal of Physiology 1986; 251: H413 – H420
4. Biro G. P. Blood substitutes and the cardiovascular system. Biomat., Art. Cells, Art. Org. 1988; 16: 595 – 606
5. Malcolm D., Kissinger D., Garrioch M. Diaspirin cross-linked hemoglobin solution as a resuscitative fluid folllwing severe hemogghage in the rat. Biomat. Art. Cells Immob. Biotech. 1992; 20: 495 – 497
6. Ning J., Peterson L. M.N., Anderson P. J., Biro G. P. Systemic hemodynamics and renal effects of unmodified human SFHS in dogs. Biomat. Art. Cells Immob. Biotech. 1992; 20: 723 – 727
7. Hess J. R., Macdonald V. W., Brinkley W. W. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. Am. J. of Physiol. 1993; 74: 1769 – 1778
8. Hess J. R., Macdonald V. W., Gomez C. S., Coppes V. Increased vascular resistance with hemoglobin-based oxygen carriers. Art. Cells, Blood Subs., Immob. Biotech. 1994; 22: 361 – 372
9. Dunlap E., Farrell L., Nigro C., Estep T., Marchand G., Burhop K. Resuscitation with diaspirin crosslinked hemoglobin in a pig model of hemorrhagic shock. Art. Cells, Blood Subs. and Immob. Biotech. 1995; 23: 39 – 61
10. Savitsky P. J., Doczi J., Black J., Arnold J. D. A Clinical Safety Trial of Stroma-Free Hemoglobin. Clinical Pharmacological Therapy 1978; 23: 73 – 80
11. Feola M., Simoni J., Angelillo R., Luhruma Z., Kabakela M., Manzombi M., Kaluila M. Clinical Trial of a Hemoglobin Based Blood Substitute in Patients with Sickle Cell Anemia. Surgery, Gynecology & Obstetrics 1992; 174: 379 – 386
12. Hughes G. S., Jacobs E. The Hemodynamic Response to Hemopure 1 (HIS) a Polymerized Bovine Hemoglobin Solution, in Normal Subjects. Proceedings of the Vth International Symposium for Blood Substitutes 1993
13. Shoemaker S., Gerber M., Evans G., Paik L., Scoggin C. Initial Clinical Experience with Recombinant Human Hemoglobin. Proceedings of the Vth International Symposium for Blood Substitutes 1993
14. Przybelski R., Kisicki J., Daily E., Bounds M. C. Mattia-Goldberg. Diaspirin Crosslinked Hemoglobin: Phase I Clinical Safety Assessment in Normal Healthy Volunteers. Proceedings of the Vth International Symposium on Blood Substitutes 1993
15. Pliura D. Human hemoglobin based blood substitutes. Presentation at the IVth Interantional Symposium on Blood Substitutes, Boston, MA., 1994
16. Goodman A. G., Goodman L. S., Gilman A. The Pharmacological Basis of Therapeutics. 7th Ed. Macmillan Publishing Co., New York, NY. 1990
17. Hedlund B. Oxygen delivery vs. dealing with reperfusion injury at resuscitation. p. 51. Proceeding of 3rd International Symposium on Blood Substitutes, San Francisco, CA., May 16–19, 1989
18. Gibson Q. H., Roughton F. J.W. The Kinetics and Equilibria of the Reactions of Nitric Oxide with Sheep Hemoglobin. J. Physiol. 1957; 136: 507 – 526
19. Furchgott R. F., Kahn M. T., Jothianandan D. Evidence supporting the proposal that endothelium-derived relaxation factor is nitric oxide. Thromb Res. 1987; 5, Suppl. VII
20. Ignarro L. J., Buga G. M., Wood K. S., Byrns R. E., Chaudhuri G. Endothelium-Derived Relaxing Factor Produced and Released from Artery and Vein is Nitric Oxide. Proceedings of the National Academy of Science 1987; 84: 9265 – 9269
21. Jovanovic A., Grbovic L., Tulic I. Endothelium-dependent relaxation in response to acetylcholine in the human uterine artery. Euro. J. Pharmacol. 1994; 256: 131 – 139
22. Feelish M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 1991; 17: S25 – 33, Suppl. 3
23. Alayashi A. I., Brockner B. A., Ryan, Frantantoni J. C., Cashon R. E. Redox reactivity of modified hemoglobins with hydrogen peroxide and nitric oxide: toxicological implications. Art. Cells, Blood Subs., Immob. Biotech. 1994; 22: 373 – 386
24. Olson J. S. Stopped flow rapid mixing measurements of ligand binding to hemoglobin and red cells. Methods Enzymol. 1981; 76: 631 – 651
25. Collins P., Burman J., Chung H., Fox K. Hemoglobin Inhibits Endothelium-Dependent Relaxation to Acetylcholine in Human Coronary Arteries In Vivo. Circulation 1993; 87: 80 – 85
26. Hodakowski G., Page R. D., Harringer W, Jacobs E. E., LaRaia P. J., Svizzero T., Guerrero J. L., Austen W. G., Vlahakes G. J. Biomat. Art. Cells Immob. Biotech. 1992; 20: 669 – 672